Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats

European Journal of Pharmacology

Volumn 373, Issue 1, 1999, Pages 21-33

  Ravati, Alexander ^a   Junker, Vera ^a   Kouklei, Maria ^a   Ahlemeyer, Barbara ^a   Culmsee, Carsten ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angiotensin converting enzyme inhibtor; Apoptosis; Ischemia, cerebral; Neuron, chick; Protection; Reactive oxygen specie

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FREE RADICAL; GLUTAMIC ACID; MOEXIPRIL; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CHICK EMBRYO; CONTROLLED STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ARTERIAL OCCLUSIVE DISEASES; BLOOD PRESSURE; BRAIN; BRAIN ISCHEMIA; CARCINOGENS; CELLS, CULTURED; CEREBRAL ARTERIES; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; FERRIC COMPOUNDS; FERROUS COMPOUNDS; FREE RADICAL SCAVENGERS; FREE RADICALS; GLUTAMIC ACID; ISOQUINOLINES; MALE; MICE; MICE, INBRED STRAINS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, LONG-EVANS; STAUROSPORINE; TETRAHYDROISOQUINOLINES;

EID: 0032980840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00211-3     Document Type: Article

References (64)

1. Anderson B., Khaper N., Dhalla A.K., Singal P.K. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can. J. Cardiol. 12:1996;1099-1104.
2. Backhauß C., Karkoutly C., Welsh M., Krieglstein J. A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmacol. Methods. 27:1992;23-27.
3. Barber D.A., Harris S.R. Oxygen free radicals and antioxidants: a review. Am. Pharm. 34:1994;26-35.
4. Bertrand R., Solary E., O'Connor P., Kohn K.W., Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211:1994;314-321.
5. Bredesen D.E. Neural apoptosis. Ann. Neurol. 38:1995;839-851.
6. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
7. Chopra M., Mc Murray J., Stewart J., Dargie H.J., Smith W.E. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin-converting enzyme inhibitors. Biochem. Soc. Trans. 18:1990;1184-1185.
8. Christensen T., Bruhn T., Balchen T., Diemer N.H. Evidence for formation of hydroxyl radicals during reperfusion after global cerebral ischemia in rats using salicylate trapping and microdialysis. Neurobiol. Dis. 1:1994;131-138.
9. Clemens J.A., Panetta J.A. Neuroprotection by antioxidants in models of global and focal ischemia. Ann. N.Y. Acad. Sci. 738:1994;250-256.
10. De Cavanagh E.M., Fraga C.G., Ferder L., Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am. J. Physiol. 272:1997;514-518.
11. Diez J., Panizo A., Hernandez M., Vega F., Sola I., Fortuno M.A., Pardo J. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension. 30:1997;1029-1034.
12. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher A.M. Angiotensin II induces apoptosis of human endothelial cells: protective effect of nitric oxide. Circ. Res. 81:1997;970-976.
13. Dzau V.J. Vascular renin-angiotensin system in hypertension: new insights into the mechanism of action of angiotensin-converting enzyme inhibitors. Am. J. Med. 84:1988;4-8.
14. Edling O., Bao G., Feelisch M., Unger T., Gohlke P. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J. Pharmacol. Exp. Ther. 275:1995;854-863.
15. Fernandes A.C., Filipe P.M., Freitas J.P., Manso C.F. Different effects of thiol and non-thiol angiotensin-converting enzyme inhibitors on copper-induced lipid and protein oxidative modification. Free Radic. Biol. Med. 20:1996;507-514.
16. Ferrari R., Cargnoni A., Curello S., Ceconi C., Boraso A., Visioli O. Protection of ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action. J. Cardiovasc. Pharmacol. 20:1992;694-704.
17. Fujii K., Weno B.L., Baumbach G.L., Heistad D.D. Effect of antihypertensive treatment on focal cerebral infarction. Hypertension. 19:1992;713-716.
18. Ginsberg M.D., Pulsinelli W.A. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann. Neurol. 36:1994;553-554.
19. Gohlke P., Linz W., Scholkens B., Van Even P., Martorana P., Unger T. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention vs. regression study. Br. J. Clin. Pract. Suppl. 84:1996;1-10.
20. Govantes C., Marin J. Effect of angiotensin-converting enzyme inhibitors on quality of life in hypertensive patients: pharmacodynamic basis. Fundam. Clin. Pharmacol. 10:1996;400-405.
21. Haas D.C., Anderson G.H. Jr., Streeten D.H. Role of angiotensin in lethal cerebral hypoperfusion during treatment of acute hypertension. Arch. Int. Med. 145:1985;1922-1924.
22. Hartwig A., Schlepegrell R. Induction of oxidative DNA damage by ferric iron in mammalian cells. Carcinogenesis. 16:1995;3009-3013.
23. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau V.J. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272:1997;19022-19026.
24. Jouquey S., Mathieu M.N., Hamon G., Chevillard C. Effect of chronic treatment with trandolapril or enalapril on brain angiotensin-converting enzyme activity in spontaneously hypertensive rats. Neuropharmacology. 34:1995;1689-1692.
25. Kabour A., Henegar J.R., Devineni V.R., Janicki J.S. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc. Res. 29:1995;543-548.
26. Kaliszewski C., Fernandez L.A., Wicke J.D. Differences in mortality rate between abrupt and progressive carotid ligation in the gerbil: role of endogenous angiotensin II. J. Cereb. Blood Flow Metab. 8:1988;149-154.
27. Kelley R.E. Blood pressure management in acute stroke. J. La. State Med. Soc. 148:1996;485-489.
28. Kohara K., Mikami H., Okuda N., Higaki J., Ogihara T. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Hypertension. 21:1993;975-979.
29. Krieglstein, J., Wolz, P., 1996. Neuroprotective effects of α-lipoic acid in cultured neurons and rodent models of focal cerebral ischemia. Free Radicals in Brain Physiology and Disorders. Academic Press, pp. 243-247.
30. Krohn A.J., Preis E., Prehn J.H.M. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J. Neurosci. 15:1998;8186-8197.
31. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
32. Lee R.M., Wang H., Smeda J.S. Perindopril treatment in the prevention of stroke in experimental animals. J. Hypertens. Suppl. 14:1996;29-33.
33. Lees K.R., Dyker A.G. Blood pressure control after acute stroke. J. Hypertens. Suppl. 14:1996;35-38.
34. Leri A., Claudio P.P., Li Q., Wang X., Reiss K., Wang S., Malhotra A., Kajstura J., Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 101:1998;1326-1342.
35. Lin S.Y., Chang H.P. Induction of superoxide dismutase and catalase activity in different rat tissues and protection from UVB irradiation after topical application of Ginkgo biloba extracts. Methods Find. Exp. Clin. Pharmacol. 19:1997;367-371.
36. Liu T.H., Beckman J.S., Freeman B.A., Hogan E.L., Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am. J. Physiol. 256:1989;589-593.
37. Liu X., Engelman R.M., Rousou J.A., Cordis G.A. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin-converting enzyme inhibitors. Cardiovasc. Drugs Ther. 6:1992;437-443.
38. Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J., Unger T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 188:1998;661-670.
39. Mak I.T., Freedman A.M., Dickens B.F., Weglicki W.B. Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endothelial cells. Biochem. Pharmacol. 40:1990;2169-2175.
40. Massoudy P., Becker B.F., Gerlach E. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat. J. Cardiovasc. Pharmacol. 23:1994;632-639.
41. Mattson M.P., Barger S.W., Begley J.G., Mark R.J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
42. Mira M.L., Silva M.M., Queiroz M.J., Manso C.F. Angiotensin-converting enzyme inhibitors as oxygen free radical scavengers. Free Radic. Res. Commun. 19:1993;173-181.
43. Noda Y., Mori A., Packer L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res. Commun. Mol. Pathol. Pharmacol. 196:1997;125-136.
44. Pellegrini-Giampietro D.E., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J. Neurochem. 51:1988;1960-1963.
45. Pettman B., Louis J.C., Sensenbrenner M.C.L. Morphological and biochemical maturation of neurons cultured in the absence of glial cells. Nature. 281:1979;378-380.
46. Prehn, J.H.M., Krieglstein, J., 1996. Reactive oxygen species in excitotoxic and apoptotic neuronal degeneration. Pharmacology of Cerebral Ischemia. Medpharm Scientific, Stuttgart, pp. 233-242.
47. 2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J. Neurochem. 68:1997;1679-1685.
48. Ratan R.R., Murphy T.H., Baraban J.M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
49. Richer C., Fornes P., Vacher E., Bruneval P., Giudicelli J.F. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal. Am. J. Cardiol. 73:1994;26-35.
50. Sadoshima S., Fujii K., Ooboshi H., Ibayashi S., Fujishima M. Angiotensin-converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats. Stroke. 24:1993;1561-1566.
51. Satoh H., Matsui K. Electrical and mechanical modulations by oxygen-derived free radical generating systems in guinea pig heart muscles. J. Pharm. Pharmacol. 49:1997;505-510.
52. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 717:1996;44-54.
53. Siesjö B.K., Agardh C.D., Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:1989;165-211.
54. Stier C.T. Jr., Benter I.F., Ahmad S., Zuo H.L., Selig N., Roethel S., Levine S., Itskovitz H.D. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension. 13:1989;115-121.
55. Stoyanovsky D.A., Wu D., Cederbaum A.I. Interaction of 1-hydroxyethyl radical with glutathione, ascorbic acid and alpha-tocopherol. Free Radic. Biol. Med. 24:1998;132-138.
56. Suzuki S., Sato H., Shimada H., Takashima N., Arakawa M. Comparative free radical scavenging action of angiotensin-converting-enzyme inhibitors with and without the sulfhydryl radical. Pharmacology. 47:1993;61-65.
57. Takeda H., Haneda T., Kikuchi K. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart. Jpn. Circ. J. 61:1997;687-694.
58. Tamura A., Graham D.J., McCulloch J., Teasdale J.M. Focal cerebral ischemia in the rat: 1. Description of the technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
59. Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13:1993;2085-2104.
60. Unger T., Badoer E., Ganten D., Lang R.E., Rettig R. Brain angiotensin: pathways and pharmacology. Circulation. 77:1988;40-54.
61. Vacher E., Fornes P., Domergue V., Richer C., Bruneval P., Giudicelli J.F. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 6:1993;951-959.
62. Welsh F.A., Sakamoto T., McKee A.E., Sims R.E. Effect of lactatacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem. 49:1987;846-851.
63. Werner C., Hoffman W.E., Kochs E., Rabito S.F., Miletich D.J. Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke. 22:1991;910-914.
64. Wiesner D.A., Dawson G. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66:1996;1418-1425.